Evolutionary rate heterogeneity of Alu repeats upstream of the APOA5 gene: do they regulate APOA5 expression?

被引:0
|
作者
Edward A. Ruiz-Narváez
Hannia Campos
机构
[1] Harvard School of Public Health,Department of Nutrition, Room 202
[2] Harvard School of Public Health,Department of Epidemiology
来源
Journal of Human Genetics | 2008年 / 53卷
关键词
repeats; Apolipoproteins; Evolution; Substitution rate;
D O I
暂无
中图分类号
学科分类号
摘要
The APOA5 gene, located in the APOA1/C3/A4/A5 gene cluster, is a key regulator of triglyceride metabolism. ApoAV plasma concentration is much lower as compared to other apolipoproteins such as apoCIII and apoAI. This is due in part to the fact that the APOC3-enhancer, which up-regulates transcription of the APOA1, APOC3, and APOA4 genes, does not increase expression of the APOA5 gene. We postulated that intervening Alu repeats in the APOA5-APOA4 intergenic region gene might be blocking action of the APOC3-enhancer over the APOA5-promoter. To search for evidence of functional significance of the intervening Alu sequences, we estimated nucleotide substitution rates of 21 pairs of Alu elements in the APOA5-APOA4 intergenic region by comparing published sequences of human and chimpanzee. Also, we scanned the intergenic region for the presence of binding sites of the insulator protein CTCF. Seven out of the nine found CTCF binding sites were located in the first half of the intergenic region. Five out of those seven CTCF binding sites were placed inside Alu elements. Based on their substitution rates, we found two clearly defined groups of Alu sequences: a slow-evolving group (mean 0.98 ± 0.18) and a fast-evolving group (mean 2.74 ± 0.54). Alu repeats with lower substitution rate tended to be located up to 14-kb upstream of the APOA5 gene, to belong to the oldest J-family and to have an opposite orientation to the APOA5 gene. Some Alu sequences may have functional relevance on the regulation of the APOA5-gene expression.
引用
收藏
页码:247 / 253
页数:6
相关论文
共 50 条
  • [11] Resolution of the functionality of APOA5 common variants
    Talmud, PJ
    Palmen, J
    Putt, W
    Humphries, SE
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 21 - 21
  • [12] Determination of the functionality of common APOA5 polymorphisms
    Talmud, PJ
    Palmen, J
    Putt, W
    Lins, L
    Humphries, SE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (31) : 28215 - 28220
  • [13] APOA5 gene polymorphisms do not affect fasting and postprandial triglyceride levels in Sardinians
    Pes, G. M.
    Buttolu, V. V.
    Errigo, A.
    Tonolo, G.
    Secchi, G.
    Maioli, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 139 - 139
  • [14] Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia
    Evans, D
    Seedorf, U
    Beil, FU
    CLINICAL GENETICS, 2005, 68 (04) : 369 - 372
  • [15] Mutation Screening of the APOA5 Gene in Subjects With Coronary Artery Disease
    Soufi, Muhidien
    Sattler, Alexander M.
    Kurt, Bilgen
    Schaefer, Juergen R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2012, 60 (07) : 1015 - 1019
  • [16] A Clinical Case of a Homozygous Deletion in the APOA5 Gene with Severe Hypertriglyceridemia
    Vasiluev, Petr Andreevich
    Ivanova, Olga N.
    Semenova, Natalia A.
    Strokova, Tatiana, V
    Taran, Natalia N.
    Chubykina, Uliana, V
    Ezhov, Marat, V
    Zakharova, Ekaterina Y.
    Dadli, Elena L.
    Kutsev, Sergey, I
    GENES, 2022, 13 (06)
  • [17] A single nucleotide polymorphism in the APOA5 gene is associated with the metabolic syndrome
    Cheung, Bernard M. Y.
    Ong, K. L.
    Thomas, G. Neil
    Jiang, C. Q.
    Lin, J. M.
    Yue, X. J.
    Liu, B.
    Wong, K. S.
    Tomlinson, Brian
    Lam, Karen S. L.
    Lam, T. H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 68 (02) : 296 - 296
  • [18] Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia
    van der Vleuten, Gerly M.
    Isaacs, Aaron
    Zeng, Wu-Wei
    ter Avest, Ewoud
    Talmud, Philippa J.
    Dallinga-Thie, Geesje M.
    van Duijn, Cornelia M.
    Stalenhoef, Anton F. H.
    de Graaf, Jacqueline
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (01): : 81 - 88
  • [19] APOPROTEIN A5 (APOA5) REDUCES ATHEROSCLEROSIS IN MICE
    Naumann, A.
    Heeren, J.
    Bruns, O. T.
    Thiery, J.
    Teupser, D.
    Merkel, M.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 37 - 38
  • [20] NOVEL RARE VARIANTS OF APOA5 GENE IN PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA
    Pisciotta, L.
    Fresa, R.
    Guido, V.
    Bellocchio, A.
    Calandra, S.
    Bertolini, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 125 - 125